Andrew J. Schwab

Insider Reports History

Location
C/O 5 Am Venture Management, Llc, 4 Embarcadero Center, Suite 3110, San Francisco, CA
Signature
/s/ Andrew J. Schwab
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew J. Schwab:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Skye Bioscience, Inc. Director, 10%+ Owner Common Stock 8.17M $28.3M $3.46 Aug 21, 2025 By 5AM Ventures VII, L.P.
Enliven Therapeutics, Inc. Director, 10%+ Owner Common Stock 960K $14.5M $15.14 Feb 23, 2023 Indirect
Camp4 Therapeutics Corp Director, 10%+ Owner Common Stock 2.63M $5.3M $2.02 Sep 11, 2025 By 5AM Ventures VI, L.P.
Skye Bioscience, Inc. Director, 10%+ Owner Common Stock 1.46M $4.98M $3.42 Aug 22, 2025 By 5AM Ventures II, L.P.
Camp4 Therapeutics Corp Director, 10%+ Owner Common Stock 2.94M $4.5M $1.53 Sep 11, 2025 By 5AM Ventures VII, L.P.
Camp4 Therapeutics Corp Director, 10%+ Owner Common Stock 303K $612K $2.02 Sep 11, 2025 By 5AM Opportunities II, L.P.
Skye Bioscience, Inc. Director, 10%+ Owner Common Stock 57.5K $197K $3.42 Aug 22, 2025 By 5AM Co-Investors II, L.P.
Skye Bioscience, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 35K $1.19K $0.02 Feb 24, 2025 Direct
Pear Therapeutics, Inc. Director, 10%+ Owner Class A Common Stock 14.6M Dec 3, 2021 by 5AM Ventures IV, L.P.
Pear Therapeutics, Inc. Director, 10%+ Owner Class A Common Stock 3.37M Dec 3, 2021 by 5AM Opportunities I, L.P.
Pear Therapeutics, Inc. Director, 10%+ Owner Class A Common Stock 610K Dec 3, 2021 by 5AM Co-Investors IV, L.P.
Enliven Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 27.6K Feb 23, 2023 Direct
Camp4 Therapeutics Corp Director, 10%+ Owner Stock Option (Right to Buy) 9K Jun 25, 2025 Direct
Camp4 Therapeutics Corp Director, 10%+ Owner Series A Prime Preferred Stock 0 Oct 15, 2024 Indirect
Camp4 Therapeutics Corp Director, 10%+ Owner Series B Preferred Stock 0 Oct 15, 2024 Indirect

Insider Reports Filed by Andrew J. Schwab

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CAMP Camp4 Therapeutics Corp Sep 11, 2025 1 $4.5M 4 Sep 15, 2025 Director, 10%+ Owner
SKYE Skye Bioscience, Inc. Aug 21, 2025 4 -$801K 4 Aug 22, 2025 Director, 10%+ Owner
CAMP Camp4 Therapeutics Corp Jun 25, 2025 1 $0 4 Jun 27, 2025 Director, 10%+ Owner
SKYE Skye Bioscience, Inc. Feb 24, 2025 1 $0 4 Feb 26, 2025 Director
SKYE Skye Bioscience, Inc. Oct 28, 2024 1 $0 4 Oct 30, 2024 Director
CAMP Camp4 Therapeutics Corp Oct 15, 2024 7 $10M 4 Oct 15, 2024 Director, 10%+ Owner
CAMP Camp4 Therapeutics Corp Oct 10, 2024 0 $0 3 Oct 10, 2024 Director, 10%+ Owner
SKYE Skye Bioscience, Inc. Sep 11, 2024 6 -$1.75M 4 Sep 13, 2024 Director, 10%+ Owner
SKYE Skye Bioscience, Inc. Mar 13, 2024 1 $4.5M 4 Mar 15, 2024 Director, 10%+ Owner
SKYE Skye Bioscience, Inc. Feb 29, 2024 1 $0 4 Mar 4, 2024 Director
SKYE Skye Bioscience, Inc. Jan 31, 2024 1 $12M 4 Feb 2, 2024 Director, 10%+ Owner
SKYE Skye Bioscience, Inc. Nov 6, 2023 1 $0 4 Nov 6, 2023 Director
SKYE Skye Bioscience, Inc. Aug 25, 2023 1 $0 4 Aug 29, 2023 Director
SKYE Skye Bioscience, Inc. Aug 18, 2023 6 $8.78M 4 Aug 22, 2023 Director, 10%+ Owner
SKYE Skye Bioscience, Inc. Aug 18, 2023 0 $0 3 Aug 22, 2023 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 1 $0 4 Apr 6, 2023 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 2 $0 4 Feb 27, 2023 Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 0 $0 3 Feb 27, 2023 Director
PEARQ Pear Therapeutics, Inc. Dec 3, 2021 4 $2M 4 Dec 7, 2021 Director, 10%+ Owner
PEARQ Pear Therapeutics, Inc. Dec 3, 2021 0 $0 3 Dec 7, 2021 Director, 10%+ Owner